(Q40581432)

English

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a

scientific article published on May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Colony stimulating factor 2

1 reference

based on heuristic

inferred from title

author name string

Valcárcel D

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sanz MA Jr

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sureda A

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sala M

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Muñoz L

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Subirá M

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Laborda R

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Clopés A

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sierra J

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

783-787

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703543

0 references

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

21 January 2018

Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - are there new strategies?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

21 January 2018

Studies of oral neutrophil levels in patients receiving G‐CSF after autologous marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

21 January 2018

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

21 January 2018

Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

21 January 2018

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

7 January 2021

based on heuristic

inferred from DOI database lookup

rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703543

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703543

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40581432&oldid=1584873193"